Correction: E-cadherin interacts with EGFR resulting in hyper-activation of ERK in multiple models of breast cancer

Oncogene. 2024 May;43(19):1488. doi: 10.1038/s41388-024-03023-2.

Gabriella C Russo^{1

2}, Ashleigh J Crawford^{1

2}, David Clark³, Julie Cui¹, Ryan Carney⁴, Michelle N Karl^{1

2}, Boyang Su⁵, Bartholomew Starich^{1

2}, Tung-Shing Lih³, Pratik Kamat^{1

2}, Qiming Zhang¹, Praful R Nair^{1

2}, Pei-Hsun Wu^{1

2}, Meng-Horng Lee¹, Hon S Leong^{5

6}, Hui Zhang³, Vito W Rebecca⁷, Denis Wirtz^{8

9}

¹ Department of Chemical and Biomolecular Engineering, Johns Hopkins University, 3400 N Charles St, Baltimore, MD, 21218, USA.
² Johns Hopkins Physical Sciences-Oncology Center and Institute for NanoBioTechnology, Johns Hopkins University, 3400 N Charles St, Baltimore, MD, 21218, USA.
³ Department of Pathology, The Johns Hopkins University School of Medicine, Baltimore, MD, 21231, USA.
⁴ Department of Biophysics, Johns Hopkins University, 3400 N Charles St, Baltimore, MD, 21218, USA.
⁵ Department of Medical Biophysics, University of Toronto, Toronto, ON, Canada.
⁶ Biological Sciences Platform, Sunnybrook Research Institute, Toronto, ON, Canada.
⁷ Department of Biochemistry and Molecular Biology, Johns Hopkins University School of Public Health, Baltimore, MD, 21231, USA.
⁸ Department of Chemical and Biomolecular Engineering, Johns Hopkins University, 3400 N Charles St, Baltimore, MD, 21218, USA. wirtz@jhu.edu.
⁹ Johns Hopkins Physical Sciences-Oncology Center and Institute for NanoBioTechnology, Johns Hopkins University, 3400 N Charles St, Baltimore, MD, 21218, USA. wirtz@jhu.edu.

No abstract available

Publication types